ASCENT THROUGH FOCUS. VALUE THROUGH PARTNERSHIP.

Trident Ridge Capital is an independent investment platform partnering with founders and management teams to acquire and build exceptional lower middle market businesses.

SCROLL

OUR FIRM

OPERATOR-INVESTORS.
STEWARD OWNERS.

We partner with Texas-based proven management teams to acquire businesses with strong fundamentals and durable competitive advantages. Our approach combines operational leadership with disciplined capital allocation to drive long-term value.

OUR APPROACH

CONTROLLED OWNERSHIP

We pursue controlling equity investments to align incentives and drive meaningful change.

OPERATIONAL EXCELLENCE

We work alongside management teams to strengthen operations and accelerate growth.

DURABLE BUSINESSES

We invest in companies with resilient models, strong cash flow, and attractive industry dynamics.

LONG-TERM PARTNERSHIP

We are committed stewards, building enduring value for our partners and stakeholders.

OUR INVESTMENT CRITERIA

BUSINESSES BUILT TO ENDURE.

We invest in founder-led businesses with durable cash flow, strong management teams, and opportunities to create long-term value.

Insurance Brokerage

IT Managed Services

Fire & Life Safety

Home Care & Home Health

Staffing for Essential Services

Utility & Energy Management

OUR TEAM
MANAGING PARTNER

JOHN
GOLDEN

As a Navy SEAL veteran with two decades of service, John brings a disciplined, mission-oriented approach to leadership and operations. His strength lies in developing adaptable, high-performing teams that solve problems, execute critical missions, and deliver results under pressure.

MANAGING PARTNER

NICOLAS
BIANCAMANO

Having served as Chief Investment Offer at a middle market family office for 17 years, Nicolas brings a cross-disciplinary expertise across investment strategy, acquisitions and dispositions, underwriting, capital structure, asset and portfolio management, and operational improvement.

MANAGING PARTNER

EMILIO
FERNANDEZ

Emilio brings 20 years of general management and commercial leadership across global healthcare and biotech firms, managing P&Ls up to $2.2B and leading teams of 300+ dependents. As VP at Novartis, he excelled at turning around underperforming businesses into top growth contributors, including building three blockbuster business units.

PERSPECTIVES

Insights on investing,
operations & leadership.